Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (251-260 of 403) with videos related to

Pageof 41
Sort By:
The Journal of Infectious Diseases|July 19, 2008
Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup BVictoria Davenport, Eleanor Groves, Rachel E Horton, et al.
Vaccine|March 21, 2012
Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccinesShamez N Ladhani, Jessica S Flood, Mary E Ramsay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in MaliNicole E Basta, Ray Borrow, Abdoulaye Berthe, et al.
Vaccine|March 31, 2025
Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020Kevin Meesters, Manish Sadarangani, Stephen A Clark, et al.
Vaccine|March 28, 2017
Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxisZiad A Memish, Jaffar A Al-Tawfiq, Malak Almasri, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2025
Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023Emma J Heymer, Stephen A Clark, Helen Campbell, et al.
The Journal of Infection|February 7, 2018
Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI)Junhong Li, Zhujun Shao, Gang Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseGeraldine Blanchard Rohner, Matthew D Snape, Dominic F Kelly, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 23, 2020
Detection of the United States <i>Neisseria meningitidis</i> urethritis clade in the United Kingdom, August and December 2019 - emergence of multiple antibiotic resistance calls for vigilanceAvril Brooks, Jay Lucidarme, Helen Campbell, et al.
BMC Infectious Diseases|June 16, 2019
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)Shamez N Ladhani, Helen Campbell, Jay Lucidarme, et al.
Pageof 41

Showing results (251-260 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Infectious Diseases|July 19, 2008
Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup BVictoria Davenport, Eleanor Groves, Rachel E Horton, et al.
Vaccine|March 21, 2012
Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccinesShamez N Ladhani, Jessica S Flood, Mary E Ramsay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in MaliNicole E Basta, Ray Borrow, Abdoulaye Berthe, et al.
Vaccine|March 31, 2025
Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020Kevin Meesters, Manish Sadarangani, Stephen A Clark, et al.
Vaccine|March 28, 2017
Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxisZiad A Memish, Jaffar A Al-Tawfiq, Malak Almasri, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 25, 2025
Use of 4CMenB vaccine in the control of an outbreak of serogroup B invasive meningococcal disease in an elderly care home, England, November 2023Emma J Heymer, Stephen A Clark, Helen Campbell, et al.
The Journal of Infection|February 7, 2018
Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI)Junhong Li, Zhujun Shao, Gang Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseGeraldine Blanchard Rohner, Matthew D Snape, Dominic F Kelly, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 23, 2020
Detection of the United States <i>Neisseria meningitidis</i> urethritis clade in the United Kingdom, August and December 2019 - emergence of multiple antibiotic resistance calls for vigilanceAvril Brooks, Jay Lucidarme, Helen Campbell, et al.
BMC Infectious Diseases|June 16, 2019
Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017)Shamez N Ladhani, Helen Campbell, Jay Lucidarme, et al.
Pageof 41